> Details

Ammar, Hania Ibrahim; Shamseldeen, Asmaa Mohammed; Shoukry, Heba Samy; Ashour, Hend; Kamar, Samaa Samir; Rashed, Laila Ahmed; Fadel, Mostafa; Srivastava, Abhay; Dhingra, Sanjiv

Metformin impairs homing ability and efficacy of mesenchymal stem cells for cardiac repair in streptozotocin-induced diabetic cardiomyopathy in rats

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: Metformin impairs homing ability and efficacy of mesenchymal stem cells for cardiac repair in streptozotocin-induced diabetic cardiomyopathy in rats
  • Contributor: Ammar, Hania Ibrahim; Shamseldeen, Asmaa Mohammed; Shoukry, Heba Samy; Ashour, Hend; Kamar, Samaa Samir; Rashed, Laila Ahmed; Fadel, Mostafa; Srivastava, Abhay; Dhingra, Sanjiv
  • imprint: American Physiological Society, 2021
  • Published in: American Journal of Physiology-Heart and Circulatory Physiology, 320 (2021) 4, Seite H1290-H1302
  • Language: English
  • DOI: 10.1152/ajpheart.00317.2020
  • ISSN: 0363-6135; 1522-1539
  • Origination:
  • Footnote:
  • Description: <jats:p> Metformin treatment reduces the efficacy of mesenchymal stem cell therapy for cardiac repair during diabetic cardiomyopathy. Stem cell therapy in diabetics may be more effective in combination with AMPK inhibitors. </jats:p>
  • Access State: Open Access